Drug Topics

JULY 25, 2024

The American College of Allergy, Asthma, and Immunology (ACAAI) recently released its 5 tips to help children and their parents stay educated on asthma peak month.

201

201

Pharmacy Times

JULY 25, 2024

Pharmacists could play a major role in answering patient questions and providing counseling about cannabis

169

169

STAT

JULY 25, 2024

UnitedHealth Group started out as a small, Minnesota health insurance company and has since morphed into a modern-day Standard Oil, exerting unmatched dominance over health care in the United States. It’s no secret that UnitedHealth is a colossus: It’s the country’s largest health insurer and the fourth-largest company of any type by revenue, just behind Apple.

Health Insurance Companies 145

Health Insurance Companies Insurance Hospitals 145

Pharmacy Times

JULY 25, 2024

Adherence and efficacy were both higher in patients with HIV who took twice-yearly lenacapavir compared to those on oral preexposure prophylaxis medication.

145

145

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

STAT

JULY 25, 2024

Insurers like UnitedHealth are profiting off of the Medicare Advantage system, and it’s causing problems for both doctors and patients. Traditional Medicare is run by the federal government, while Medicare Advantage health insurance plans are operated by private companies like UnitedHealth. These privately run plans are still subsidized by government funds.

Insurance 141

Insurance Hospitals 141

Pharmacy Times

JULY 25, 2024

Despite the century-long period of virus evolution, 6 of the 11 primates that received a cytomegalovirus-expressed flu vaccine survived the exposure to H5N1 flu.

Vaccines 144

Vaccines 144

Pharmacy Times

JULY 25, 2024

Patients without insurance may not be able to afford the biosimilar adalimumab-adbm, even if it is available at a more affordable price than its reference product.

Insurance 132

Insurance 132

STAT

JULY 25, 2024

Many people were stunned when an FDA advisory committee voted “no” on a new drug application for MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD) earlier this summer. I was not among them. Several things were stacked against approval: The FDA greenlights only about 50 new drugs each year. Drug development is a high-risk business with an overall success rate between 10% and 20%.

FDA 130

FDA Compounding 130

Pharmacy Times

JULY 25, 2024

The Lancet published data from DELTA 1 and DELTA 2 trials that displayed treatment success among individuals treated with delgocitinib cream.

132

132

STAT

JULY 25, 2024

A little-known office within the Department of Health and Human Services is getting a shot in the arm as part of a major agency reorganization announced on Thursday. The Office of the National Coordinator for Health Information Technology, better known as ONC, regulates data standards for health care systems, including the electronic health records that underpin patient care and billing.

Insurance 130

Insurance Patient Care 130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JULY 25, 2024

AIC100 could meet an unmet medical need to effectively treat individuals with anaplastic thyroid cancer — the most aggressive form of the disease.

FDA 132

FDA 132

Fierce Healthcare

JULY 25, 2024

CVS Health's Caremark has agreed to pay $45 million to Illinois to settle allegations that it failed to pass through rebates in a recent contract, according to a new report. | CVS Health's Caremark has agreed to pay $45 million to Illinois to settle allegations that it failed to pass through rebates in a recent contract, according to a new report.

126

126

STAT

JULY 25, 2024

Breast cancer surgeons have tended not to push patients towards bilateral mastectomy, since data have long shown that the complete removal of both breasts doesn’t improve survival. New data from a large epidemiological study affirmed that, but an accompanying finding is puzzling. Breast cancer survivors who ended up developing a second breast cancer in the opposite or contralateral breast had a higher risk of death, even though preventing that cancer with surgery didn’t change outc

Hospitals 126

Hospitals 126

Pharmacy Times

JULY 25, 2024

Despite Muslim patients’ need for halal medication, more than 80% of pharmacists were found to lack knowledge about where to look to find alternative medications that are halal.

123

123

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

JULY 25, 2024

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. Welcome back! I’ve been working from home almost this entire summer because of construction on the Red Line. I hate the MBTA. Boston readers know what I mean. This week: “Muscarinics” are hot and Neurocrine Biosciences is the next biotech with a big study readout.

119

119

Pharmacy Times

JULY 25, 2024

New strategies can improve cholesterol management in patients with ASCVD.

123

123

STAT

JULY 25, 2024

It takes years for most people with a rare disease to learn what is ailing them. Their symptoms may be crystal clear, but the cause isn’t. Efforts by the Department of Justice — an agency not known for its medical expertise — will make things even harder for the millions of Americans , half of them children, with one of these diseases.

119

119

Pharmacy Times

JULY 25, 2024

Tune into this episode of “Public Health Matters” to hear how Walmart is leveraging its network to provide HIV care and specialty pharmacy services and how integrating community pharmacy outreach is significant for patients.

Specialty Pharmacies 123

Specialty Pharmacies Community Pharmacies 123

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

JULY 25, 2024

Universal Health Services (UHS) raised its full-year revenue and earnings guidance buoyed by strong financial performance in the past six months thanks to acute care growth. | Universal Health Services saw growth in Q2 in profit and revenue offset by lower admissions at its behavioral health facilities.

117

117

STAT

JULY 25, 2024

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Medicare regulators’ proposal to start paying for some digital therapeutics products created a wave of enthusiasm when it was released earlier this month.

114

114

Drug Topics

JULY 25, 2024

Galderma said the FDA has accepted the company’s Biologics License Application for the therapy based on data from the trials.

FDA 112

FDA 112

STAT

JULY 25, 2024

LONDON — In the booming field of weight loss drugs, Roche has been riding high in recent months, with back-to-back positive studies of two experimental medicines that sent the company’s shares up — and those of its rivals down. But on Thursday, company executives faced an onslaught of questions from analysts during an earnings presentation about what came next for the company’s weight loss drugs and how they would stand apart in the wildly competitive field.

112

112

pharmaphorum

JULY 25, 2024

There has been a gene therapy on the market for people with the bleeding disorder haemophilia A since 2022, but take-up has been very slow. Pfizer and Sangamo are hoping for a faster trajectory with their experimental treatment.The partners' one-shot giroctocogene fitelparvovec therapy has cleared a phase 3 trial, showing it was better than regular prophylaxis injections with Factor VIII (FVIII) replacement therapies at reducing bleeding episodes, and could now be heading for regulatory review.

110

110

STAT

JULY 25, 2024

For Dr. Jeremy Faust, July 1 is like New Year’s Day. That’s when thousands of new medical school graduates enter teaching hospitals across the country and provide care to patients as doctors for the first time. “Everything is new and full of possibilities,” said Faust, an emergency physician at Brigham and Women’s Hospital.

Hospitals 112

Hospitals Medical Schools 112

pharmaphorum

JULY 25, 2024

Tune in to the Reverba podcast featuring CEO Cheryl Lubbert as she discusses patient engagement throughout the product lifecycle, sharing insights and strategies for success.

110

110

STAT

JULY 25, 2024

What makes UnitedHealth similar to Standard Oil? Is Viking Therapeutics an attractive acquisition target? And is Adam good at math? We discuss all that and more in this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. Tara Bannow, our hospitals and insurance reporter, joins us to talk about a new investigation that shows how UnitedHealth wields its unrivaled physician empire to boost its profits and expand its influence.

Insurance 111

Insurance FDA Hospitals 111

pharmaphorum

JULY 25, 2024

Exploring the impact of ageing on Europe and the need to prioritise neurological conditions. Understand the role of neuroscience in addressing these issues.

109

109

Fierce Pharma

JULY 25, 2024

Three months after bagging FDA approval, Pfizer’s hemophilia B gene therapy has been cleared to expand its reach across the pond. | The company's first gene therapy will debut in Europe as Durveqtix. In the U.S., the drug is approved under the brand name Beqvez.

FDA 107

FDA 107

pharmaphorum

JULY 25, 2024

Ipsen has signed yet another portfolio-expanding deal – its fifth of the year so far – claiming rights outside the US to a drug for common brain cancer glioma from Day One Biopharmaceuticals.

105

105

STAT

JULY 25, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning! Before we get to biotech, check out STAT’s deep dive into how UnitedHealth mobilizes a massive network of physicians and milked the health care system for profit.

104

104

pharmaphorum

JULY 25, 2024

European pharma groups AstraZeneca, Sanofi, and Roche all raise their financial guidance for the year on stronger sales growth.

105

105

Fierce Healthcare

JULY 25, 2024

Ascension Illinois is selling several hospitals and their associated physician practices, post-acute and senior living facilities to Prime Healthcare. | The agreement includes nine hospitals and four additional sites of care, all throughout Illinois. Prime said it would invest $250 million in facility upgrades, capital improvements, technology and system upgrades.

Hospitals 103

Hospitals 103

pharmaphorum

JULY 25, 2024

NICE clears NHS use of Boehringer's clot-busting drug Metalyse for acute ischaemic stroke, saying it could 'save millions'

104

104